{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:45:13Z","timestamp":1792118713408,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.celrep.2025.116463","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:15:36Z","timestamp":1761128136000},"page":"116463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Metabolic regulation of immunity in the tumor microenvironment"],"prefix":"10.1016","volume":"44","author":[{"given":"Shen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116463_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate Limits T Cell Proliferation via the NAD(H) Redox State","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116463_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189005","article-title":"Adenosine in cancer immunotherapy: Taking off on a new plane","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib6","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116463_bib9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2025.116463_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116463_bib11","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116463_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7150\/thno.105423","article-title":"B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2025.116463_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2025.116463_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib15","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib16","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116463_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cmet.2017.08.012","article-title":"Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses","volume":"26","author":"Thwe","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u03f5 supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-024-55768-9","article-title":"Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation","volume":"16","author":"Yi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116463_bib22","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib23","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3389\/fimmu.2018.02489","article-title":"Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response","volume":"9","author":"Basit","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80721","article-title":"Arginase 1 is a key driver of immune suppression in pancreatic cancer","volume":"12","author":"Menjivar","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.116463_bib25","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116463_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","article-title":"Serine Is an Essential Metabolite for Effector T Cell Expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib29","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib30","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate Metabolism in Human Lung Tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2020.02.042","article-title":"Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression","volume":"180","author":"Devalaraja","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116463_bib34","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41423-024-01230-1","article-title":"Kynurenine-AhR reduces T-cell infiltration and induces a delayed T-cell immune response by suppressing the STAT1-CXCL9\/CXCL10 axis in tuberculosis","volume":"21","author":"Liu","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj3301","article-title":"Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival","volume":"10","author":"Haley","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.116463_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309885","article-title":"Identification of Hypoxia-ALCAM(high) Macrophage- Exhausted T Cell Axis in Tumor Microenvironment Remodeling for Immunotherapy Resistance","volume":"11","author":"Xun","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2025.116463_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","article-title":"Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.celrep.2025.116463_bib40","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1038\/s41467-021-25962-0","article-title":"Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer","volume":"12","author":"Hammerl","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib41","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib43","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/2159-8290.CD-20-0569","article-title":"The Complex Integration of T-cell Metabolism and Immunotherapy","volume":"11","author":"Madden","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2025.116463_bib44","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.celrep.2019.03.037","article-title":"Autophagy Regulation of Metabolism Is Required for CD8(+) T Cell Anti-tumor Immunity","volume":"27","author":"DeVorkin","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116463_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116463_bib47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116463_bib50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib51","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2025.116463_bib52","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","article-title":"Lipid signalling enforces functional specialization of T(reg) cells in tumours","volume":"591","author":"Lim","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210564","article-title":"Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer","volume":"219","author":"Masetti","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116463_bib57","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-024-00743-1","article-title":"Macrophages and T cells in metabolic disorder-associated cancers","volume":"24","author":"Taranto","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib58","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116463_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1584987","article-title":"Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance","volume":"13","author":"Lin","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2025.116463_bib61","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/s41467-018-07505-2","article-title":"Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression","volume":"9","author":"Rice","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-025-00731-z","article-title":"Neutrophil extracellular traps in tumor metabolism and microenvironment","volume":"13","author":"Liu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.celrep.2025.116463_bib63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41590-025-02102-0","article-title":"B cell immunometabolism in health and disease","volume":"26","author":"Martinis","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib64","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ijc.35229","article-title":"Tumor-derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL-10-producing regulatory B cells through direct and indirect signaling pathways","volume":"156","author":"Muraoka","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib65","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1201920","article-title":"Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor alpha","volume":"190","author":"Wejksza","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747780","article-title":"Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer","volume":"12","author":"Tousif","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib67","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.immuni.2022.07.017","article-title":"Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116463_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116463_bib69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41698-025-00891-z","article-title":"Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma","volume":"9","author":"Su","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib72","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116463_bib73","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1222719","article-title":"Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib75","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.csbj.2021.03.033","article-title":"Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma","volume":"19","author":"Zeng","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.celrep.2025.116463_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005644","article-title":"Activated B cells suppress T-cell function through metabolic competition","volume":"10","author":"Imahashi","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.it.2025.02.015","article-title":"The unusual metabolism of germinal center B cells","volume":"46","author":"Gracie","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1101433","article-title":"Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells","volume":"14","author":"Barbieri","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib79","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib80","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.4049\/jimmunol.168.8.3771","article-title":"Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses","volume":"168","author":"Mellor","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib81","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","article-title":"Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling","volume":"82","author":"Fiore","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.116463_bib82","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib83","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","article-title":"CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis","volume":"71","author":"Stagg","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.979154","article-title":"Tumor acidity: From hallmark of cancer to target of treatment","volume":"12","author":"Bogdanov","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib86","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41590-024-01973-z","article-title":"GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity","volume":"25","author":"Yan","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116463_bib87","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.immuni.2021.05.007","article-title":"GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116463_bib88","doi-asserted-by":"crossref","first-page":"611","DOI":"10.20517\/cdr.2023.60","article-title":"Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1\/PD-L1 treatment","volume":"6","author":"Laubach","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.celrep.2025.116463_bib89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biopha.2018.03.008","article-title":"Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells","volume":"102","author":"Amaral","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.celrep.2025.116463_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317710823","article-title":"UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.celrep.2025.116463_bib91","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.18632\/aging.103777","article-title":"Metformin suppresses Nrf2-mediated chemoresistance in hepatocellular carcinoma cells by increasing glycolysis","volume":"12","author":"Cai","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.celrep.2025.116463_bib92","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib93","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib94","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1200\/JCO.23.02659","article-title":"Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study","volume":"42","author":"Philip","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib95","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","article-title":"A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia","volume":"24","author":"Pardee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib96","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib97","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2767-9764.CRC-24-0082","article-title":"First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARalpha, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors","volume":"4","author":"Yarchoan","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.celrep.2025.116463_bib98","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10637-023-01416-w","article-title":"Phase I\/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma","volume":"42","author":"Huynh","year":"2024","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.celrep.2025.116463_bib100","article-title":"First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours","volume":"3","author":"Naing","year":"2024","journal-title":"BMJ Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib101","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/1078-0432.CCR-21-2972","article-title":"Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib102","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/jamaoncol.2022.3511","article-title":"Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial","volume":"8","author":"Tannir","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00262-024-03640-6","article-title":"A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer","volume":"73","author":"Falchook","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2025.116463_bib104","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/1078-0432.CCR-21-2742","article-title":"Phase I Study of Taminadenant (PBF509\/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer","volume":"28","author":"Chiappori","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116463_bib105","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.22.00227","article-title":"COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer","volume":"40","author":"Herbst","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.116463_bib106","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: New views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.celrep.2025.116463_bib107","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1111\/bph.13616","article-title":"Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer","volume":"173","author":"Coothankandaswamy","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.celrep.2025.116463_bib108","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","article-title":"Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.116463_bib109","doi-asserted-by":"crossref","first-page":"443S","DOI":"10.1080\/07315724.2001.10719183","article-title":"Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?","volume":"20","author":"Epner","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.celrep.2025.116463_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/01635580701525877","article-title":"Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial","volume":"60","author":"Durando","year":"2008","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib111","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1207\/S15327914NC422_2","article-title":"Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction","volume":"42","author":"Epner","year":"2002","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib112","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ijc.34701","article-title":"Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial","volume":"154","author":"Ligorio","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2025.116463_bib113","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejca.2022.05.046","article-title":"Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial","volume":"172","author":"Ligorio","year":"2022","journal-title":"Eur. J. Cancer"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725012343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725012343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:35:42Z","timestamp":1776918942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725012343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":113,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2211124725012343"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116463","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic regulation of immunity in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116463"}}